Zimmer Biomet Holdings, Inc. ZBH

91.04 1.35 1.51% as of 25 Sep
Market cap
$17.1B
P/E
22.0×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Zimmer Biomet Holdings, Inc. (ZBH) P/B ratio

As of 25 September 2026, Zimmer Biomet Holdings, Inc. (ZBH) trades at a P/B ratio of 1.4×. Over the past ten years it has ranged from 1.2× (May 2026) to 3.0× (February 2015); the current reading is higher than 3% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 1.4× (18.51%)
FY2024 1.7× (15.23%)
FY2023 2.0× (8.55%)
FY2022 2.2× 9.20%
FY2021 2.0× (19.98%)
FY2020 2.5× 5.55%
FY2019 2.4× 32.34%
FY2018 1.8× (12.30%)
FY2017 2.1× (0.13%)
FY2016 2.1× 9.93%

Quarterly

Period P/B ratio Change
Jun 2026 1.3× (5.80%)
Mar 2026 1.4× (0.78%)
Dec 2025 1.4× (8.32%)
Sep 2025 1.5× 6.14%
42 more quarters

Against its own ten years

Low 1.2× High 3.0×
Ten-year median 2.1×
Current reading's percentile 3

P/B ratio against peers

Company P/B ratio
BIO.B Bio-Rad Laboratories, Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. 1.4×
BIO Bio-Rad Laboratories, Inc. compare 1.4×
PHG Koninklijke Philips N.V. compare 1.8×
GMED Globus Medical, Inc. compare 2.1×
SNN Smith & Nephew SNATS, Inc. compare 2.3×
GEHC GE HealthCare Technologies Inc. compare 2.7×
STE STERIS plc compare 2.8×
PEN Penumbra, Inc. compare 8.2×
Medical Devices industry median 2.5×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on ZBH